Rapt Therapeutics, Inc. (RAPT)
33.38
-2.46
(-6.86%)
USD |
NASDAQ |
Dec 30, 16:00
33.50
+0.12
(+0.36%)
After-Hours: 20:00
Rapt Therapeutics EPS Diluted (Quarterly): -0.652 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Replimune Group, Inc. | -0.9041 |
| Olema Pharmaceuticals, Inc. | -0.4924 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.58M |
| Total Expenses (Quarterly) | 17.58M |
| Enterprise Value | 397.28M |
| Earnings Yield | -31.49% |
| Normalized Earnings Yield | -31.49 |